The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
if you can promote then the mitochondria be a little bit less efficient so they have to burn more fat to generate the same amount of atp this we've shown in various forms preclinical models mice rats with fatty liver nash liver fibrosis it reverses fatty liver through these mechanisms reverses nash reverses the insulin resistance through reductions in dags acetyl-coa reverses diabetes and zdf models
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.